Nutritional compositions containing synergistic combination and uses thereof

US9609888B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9609888-B2
Application numberUS-201313955492-A
CountryUS
Kind codeB2
Filing dateJul 31, 2013
Priority dateJul 31, 2013
Publication dateApr 4, 2017
Grant dateApr 4, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A composition and method for enhancing brain development in a pediatric subject, the method including administering to the pediatric subject a nutritional composition having up to about 7 g/100 kcal of a fat or lipid source, wherein the fat or lipid source includes at least about 0.5 mg/100 kcal of milk or non-milk polar lipids; up to about 5 g/100 kcal of a protein source; at least about 15 mg/100 kcal of lactoferrin from a non-human source; about 0.015 g/100 kcal to about 0.15 g/100 kcal of a prebiotic composition including polydextrose and/or galactooligosaccharide; and at least about 5 mg/100 kcal of a source of long chain polyunsaturated fatty acids.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for enhancing brain development in a pediatric subject, the method comprising administering to the pediatric subject a nutritional composition comprising: a. up to about 7 g/100 kcal of a fat or lipid source, wherein the fat or lipid source comprises at least about 0.5 mg/100 kcal polar lipids, wherein the polar lipids comprise gangliosides and phospholipids, and further wherein the gangliosides are present at a level of about 0.5 mg/100 kcal to about 18 mg/100 kcal, and the phospholipids are present at a level of about 20 mg/100 kcal to about 250 mg/100 kcal; b. up to about 5 g/100 kcal of a protein source; c. at least about 15 mg/100 kcal of lactoferrin from a non-human source; d. a prebiotic composition, wherein at least 20% of the prebiotic composition comprises polydextrose, galactooligosaccharide or a combination thereof; e. at least about 5 mg/100 kcal of a source of long chain polyunsaturated fatty acids comprising docosahexaenoic acid; and f. a preservative. 2. The method of claim 1 , wherein the polar lipids are present at a level of about 0.5 mg/100 kcal to about 470 mg/100 kcal. 3. The method of claim 2 , wherein the polar lipids are present at a level of about 10 mg/100 kcal to about 350 mg/100 kcal. 4. The method of claim 3 , wherein the polar lipids are present at a level of about 20 mg/100 kcal to about 260 mg/100 kcal. 5. The method of claim 1 , wherein lactoferrin is present at a level of about 10 mg/100 kcal to about 200 mg/100 kcal. 6. The method of claim 5 , wherein the lactoferrin is bovine lactoferrin. 7. The method of claim 1 , wherein the source of long chain polyunsaturated fatty acids is present more preferably from about 5 mg/100 kcal to about 75 mg/100 kcal. 8. The method of claim 1 , wherein the nutritional composition is an infant formula or a growing up milk. 9. A nutritional composition for enhancing brain development in a pediatric subject, comprising: a. up to about 7 g/100 kcal of a fat or lipid source, wherein the fat or lipid source comprises at least about 0.5 mg/100 kcal polar lipids, wherein the polar lipids comprise gangliosides and phospholipids, and further wherein the gangliosides are present at a level of about 0.5 mg/100 kcal to about 18 mg/100 kcal, and the phospholipids are present at a level of about 20 mg/100 kcal to about 250 mg/100 kcal; b. up to about 5 g/100 kcal of a protein source; c. at least about 15 mg/100 kcal of lactoferrin from a non-human source; d. a prebiotic composition, wherein at least 20% of the prebiotic composition comprises polydextrose, galactooligosaccharide or a combination thereof; e. at least about 5 mg/100 kcal of a source of long chain polyunsaturated fatty acids comprising docosahexaenoic acid; and f. a preservative. 10. The composition of claim 9 , wherein the polar lipids are present at a level of about 0.5 mg/100 kcal to about 470 mg/100 kcal. 11. The composition of claim 10 , wherein the polar lipids are present at a level of about 10 mg/100 kcal to about 350 mg/100 kcal. 12. The composition of claim 11 , wherein the polar lipids are present at a level of about 20 mg/100 kcal to about 260 mg/100 kcal. 13. The composition of claim 9 , wherein lactoferrin is present at a level of about 15 mg/100 kcal to about 300 mg/100 kcal. 14. The composition of claim 13 , wherein the lactoferrin is bovine lactoferrin. 15. The composition of claim 9 , wherein the source of long chain polyunsaturated fatty acids is present more preferably from about 5 mg/100 kcal to about 75 mg/100 kcal. 16. The composition of claim 9 , wherein the nutritional composition is an infant formula or a growing up milk. 17. The method of claim 1 , wherein the prebiotic composition is present in the nutritional composition from about 1.0 g/L to about 10.0 g/L. 18. The composition of claim 9 , wherein the prebiotic composition is present from about 1.0 g/L to about 10.0 g/L. 19. The method of claim 1 , wherein the pediatric subject is an infant and further wherein the gangliosides are present at a level of about 0.5 mg/100 kcal to about 12 mg/100 kcal and the phospholipids are present at a level of about 20 mg/100 kcal to about 50 mg/100 kcal. 20. The method of claim 1 , wherein the pediatric subject is an infant between birth and 6 months of age, and further wherein the gangliosides are present at a level of about 0.5 mg/100 kcal to about 9 mg/100 kcal and the phospholipids are present at a level of about 20 mg/100 kcal to about 150 mg/100 kcal.

Assignees

Inventors

Classifications

  • from milk · CPC title

  • one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin · CPC title

  • A23L33/26Primary

    Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose · CPC title

  • having three or more double bonds, e.g. linolenic (eicosanoids, e.g. leukotrienes A61K31/557) · CPC title

  • Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9609888B2 cover?
A composition and method for enhancing brain development in a pediatric subject, the method including administering to the pediatric subject a nutritional composition having up to about 7 g/100 kcal of a fat or lipid source, wherein the fat or lipid source includes at least about 0.5 mg/100 kcal of milk or non-milk polar lipids; up to about 5 g/100 kcal of a protein source; at least about 15 mg…
Who is the assignee on this patent?
Mead Johnson Nutrition Co
What technology area does this patent fall under?
Primary CPC classification A23L33/26. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).